💡 Dual-Action Glycemic Control:

• Linagliptin slows degradation of incretin hormones (GLP‑1, GIP), enhancing insulin release and reducing glucagon in a glucose-dependent way.

• Metformin Hydrochloride lowers hepatic glucose production, reduces intestinal glucose absorption, and increases insulin sensitivity Oshudh+11Amar Pharma+11PlaneWebFront+11.

📉 Improves HbA1c & Fasting/Post‑Meal Glucose: Effective when diet and exercise alone are insufficient .

🕒 Convenient Dosing: Initial regimen is one tablet twice daily with meals; may escalate up to Linagliptin 2.5 mg + Metformin 1000 mg twice daily based on tolerability and control .

🍽️ Minimizes GI Side Effects: Taking with meals reduces metformin-related gastrointestinal impacts like nausea and diarrhea Reddit+11Amar Pharma+11PlaneWebFront+11.

⚠️ Low Risk of Hypoglycemia: Minimal risk unless used with sulfonylureas or insulin Pharmacist BD+1Amar Pharma+1.

🩸 Cost-Effective in Bangladesh: Priced around ৳12–13 per tablet, making it affordable for long-term therapy Pharmacist BD+1Reddit+1.

🧾 Trusted Manufacturer & Formulation: Produced by The ACME Laboratories Ltd. in Bangladesh, using licensed Linagliptin and Metformin formulations